In the latest report from the Evernorth Research Institute, learn how biosimilars expand patient choice, lower specialty medication costs, and deliver meaningful savings to employers and patients.
Uncovering news and insights
We’re constantly working to unlock new ideas that can drive progress. Here you’ll find research, data analysis, and expert perspectives to help you create better outcomes for your people.
Close search filters
Changing filters will change the listed Success Criteria and Techniques
Search results (292)
Article
The Importance of a Robust Clinical Model for Specialty Care
December 22, 2022
A recent survey of pulmonary hypertension prescribers’ experiences with specialty pharmacies uncovered some key themes for plan sponsors to consider.
Article
Understanding Alzheimer’s Disease
December 09, 2022
Alzheimer’s Disease affects 5.8 million Americans and costs the U.S. health care system more than $300 billion annually, with both figures trending upwards.
Article
Express Scripts To Begin Adding Inflammatory Conditions Biosimilars to Largest Formularies Next Year
December 05, 2022
Article
The Pharmacy Benefit Management Team: Helping Patients Access Affordable Prescription Drugs Safely and Efficiently
November 28, 2022
Pharmacy benefit managers (PBMs) like Express Scripts are uniquely positioned to help patients in numerous ways.
Video
Strategies to Encourage the Adoption of Biosimilars
November 04, 2022
Here are three ways plan sponsors can promote and manage the appropriate use of biosimilars to improve drug affordability and access for members.
Article
High Specialty Drug Costs: A Challenge in Need of Powerful Protection
November 02, 2022
Plan sponsors are overlooking simple strategies to increase specialty medication adherence.
